reSeArcH Article
Number of UMI for reads with CALR locus of interest 01234 >5
ET01
10X 3’ v2 GoT
MF01
10X 3’ v2 GoT
ET05
10X 3’ v3 GoT
MF05
10X 3’ v2 GoT
ET02
10X 3’ v2 GoT
MF02
10X 3’ v3 GoT
ET03
10X 3’ v2 GoT
MF03
10X 3’ v3 GoT
ET04
10X 3’ v2 GoT
MF04
10X 3’ v3 GoT
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
1
4
16
64
10x 10x GoT
Ta rgeted CALR
locus
CALR gene
0
UMI counts per cell
UMI counts per cell
ET01
3’ v2
ET04
3’ v2
ET03
3’ v2
ET02
3’ v2
ET05
3’ v3
MF01
3’ v2
MF04
3’ v3
MF03
3’ v3
MF02
3’ v3
MF05
3’ v2
a
b
ET01
ET02
ET03
ET04
ET05
MF01
MF02
MF03
MF04
MF05
Essential thrombocythemia
Essential thrombocythemia
Essential thrombocythemia
Essential thrombocythemia
Essential thrombocythemia
Myelofibrosis
Myelofibrosis
Myelofibrosis
Myelofibrosis
Myelofibrosis
BM
BM
BM
BM
BM
PB
PB
PB
PB
PB
L367Tfs*46 (Type 1)
K385Nfs*47 (Type 2)
L367Tfs*46 (Type 1)
L367Tfs*46 (Type 1)
A382Rfs*58
K385Nfs*47 (Type 2)
L367Tfs*46 (Type 1)
L367Tfs*46 (Type 1)
K385Nfs*47 (Type 2)
K385Nfs*47 (Type 2)
6811
1135
3587
5131
2217
965
2631
3840
3657
8475
90%
82%
90%
92%
82%
51%
94%
90%
92%
74%
XBP1 splice site
XBP1 splice site
NFE2 (E261Afs*3), SF3B1 (H662D)
Patient ID Diagnosis Source CALR variant Cell #% genotyped Other targets
c
d
MF05
MF01
ET04
ET03
ET02
ET01
Healthy control
Number of genes per cell
n = 7,927
0 4000300020001000 5000 0 20,00040,00060,000
Number of UMI per cell
n = 6,811
n = 1,135
n = 3,587
n = 5,131
n = 965
n = 8,475
Cell #
Extended Data Fig. 3 | GoT captures genotyping information of single
cells through cDNA. a, Percentage of cells by number of UMIs with the
CALR-mutation locus captured in standard 10x data (left panels) and GoT
data (right panels) (see c for cell numbers in each sample). b, Number of
UMIs per cell of CALR transcript from standard 10x data (blue shading)
or targeted CALR locus from standard 10x or GoT (pink shading) (see
c for cell numbers in each sample). c, Summary of clinical, pathological
and GoT data from patients with CALR-mutated myeloproliferative
neoplasms. BM, bone marrow; PB, peripheral blood. d, Number of genes
per cell (left) and number of UMIs per cell (right) from published standard
10x data of healthy control CD34+ cells and 10x data from 3′ v.2 chemistry
of CD34+ cells from patient samples that underwent concurrent GoT, after
random downsampling of the reads from each sample to 50 million reads
× 3 iterations, showing that the extra cycle of PCR and portioning a small
aliquot from the 10x cDNA library for GoT using 3′ v.2 chemistry does not
compromise scRNA-seq data.